Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes. / Højberg, P V; Vilsbøll, T; Zander, M; Knop, F K; Krarup, T; Vølund, A; Holst, Jens Juul; Madsbad, S.

    In: Diabetic Medicine Online, Vol. 25, No. 11, 11.2008, p. 1268-75.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. / Højberg, P V; Vilsbøll, T; Rabøl, R; Knop, F K; Bache, M; Krarup, T; Holst, Jens Juul; Madsbad, S.

    In: Diabetologia, Vol. 52, No. 2, 2008, p. 199-207.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Overview of incretin hormones. / Holst, Jens Juul; Lasalle, JR.

    In: Journal of Family Practice, Vol. 57, No. 9, 2008, p. 53-59.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide-1, glucose homeostasis and diabetes. / Holst, Jens Juul; Deacon, Carolyn F; Vilsbøll, Tina; Krarup, Thure; Madsbad, Sten.

    In: Trends in Molecular Medicine, Vol. 14, No. 4, 2008, p. 161-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The incretin system and its role in type 2 diabetes mellitus. / Holst, Jens Juul; Vilsbøll, Tina; Deacon, Carolyn F.

    In: Molecular and Cellular Endocrinology, Vol. 297, No. 1-2, 2008, p. 127-136.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The physiology and pharmacology of incretins in type 2 diabetes mellitus. / Holst, Jens Juul.

    In: Diabetes, Obesity and Metabolism, Vol. 10, No. Suppl. 3, 2008, p. 14-21.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. / Hellström, P M; Näslund, E; Edholm, T; Schmidt, P T; Kristensen, J; Theodorsson, E; Holst, Jens Juul; Efendic, S.

    In: Neurogastroenterology and Motility Online, Vol. 20, No. 6, 06.2008, p. 649-59.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. / Hellstrom, P.M.; Naslund, E.; Edholm, T.; Schmidt, P.T.; Kristensen, J.; Theodorsson, E.; Holst, Jens Juul; Efendic, S.

    In: Neurogastroenterology and Motility, Vol. 20, No. 6, 2008, p. 649-659.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. / Greenfield, Jerry R; Farooqi, I Sadaf; Keogh, Julia M; Henning, Elana; Habib, Abdella M; Blackwood, Anthea; Reimann, Frank; Holst, Jens J; Gribble, Fiona M.

    In: American Journal of Clinical Nutrition, Vol. 89, No. 1, 2008, p. 106-13.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract. / Gottschalck, Ida B.; Jeppesen, Palle Bekker; Holst, Jens Juul; Henriksen, D.B.

    In: Scandinavian Journal of Gastroenterology, Vol. 43, No. 8, 2008, p. 929-937.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207